ICD-10-CM Billable Code

R77.2

Abnormality of alphafetoprotein

Clinical Classification Guidelines

Medical Intelligence & Overview

An abnormality of alphafetoprotein (AFP) refers to atypical levels of this protein in the blood. AFP is a protein normally produced during fetal development, primarily by the liver and yolk sac. After birth, AFP levels typically decrease to very low levels, but they can become elevated or decreased due to various health conditions. This abnormality is identified through blood tests and can be a sign of underlying issues, particularly related to liver health and certain cancers. Recognizing AFP abnormalities helps healthcare providers in diagnosing and monitoring diseases but doesn't provide a standalone diagnosis.

Causes & Symptoms

Clinical Causes: Liver diseases such as hepatocellular carcinoma or cirrhosis Pregnancy-related conditions, including neural tube defects or fetal abnormalities Germ cell tumors, such as testicular or ovarian cancers Liver regeneration after injury or surgery Certain benign liver conditions that cause liver cell turnover Other malignancies that can affect AFP levels

Key Symptoms: No specific symptoms directly linked to AFP abnormalities; often detected through screening or diagnostic tests Signs related to underlying conditions like liver dysfunction or tumors may include fatigue, abdominal swelling, jaundice, or unexplained weight loss In pregnancy, abnormal AFP results may lead to further testing for fetal abnormalities or gestational issues

Diagnostic & Treatment

Diagnosis Path: Diagnosis begins with blood testing to measure AFP levels. If AFP levels are abnormal, additional diagnostic procedures may be performed, such as imaging tests like ultrasound, CT scans, or MRI scans to locate potential tumors or liver abnormalities. Biopsy might be recommended to confirm the presence of malignancies. The context of pregnancy and fetal development is also considered when interpreting AFP levels in expectant mothers.

Treatment Protocols: Treatment depends on the underlying cause of the abnormal AFP levels. Managing liver diseases, treating cancers, or addressing pregnancy-related issues are common approaches. Medical interventions may include surgery, chemotherapy, radiation therapy, or other specialized treatments. For pregnant women, ongoing monitoring and additional prenatal assessments are usually part of care. It is important to work with healthcare providers for a tailored plan based on the specific diagnosis.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is R77.2 a billable ICD-10 code?
Yes, R77.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report R77.2?
Clinical documentation must specify the nature of Abnormality of alphafetoprotein and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

abnormality alphafetoprotein